Half-molar sodium-lactate solution has a beneficial effect in patients after coronary artery bypass grafting
- 315 Downloads
To compare two solutions for fluid resuscitation in post-coronary artery bypass grafting (CABG) surgery patients: Ringer’s lactate (RL) versus a new solution containing half-molar sodium-lactate (HL).
Prospective randomized open label study.
The first 12 h post-CABG surgery in an intensive care unit (ICU).
There were 230 patients enrolled in the study: 208 were analyzed, with 109 from the HL group and 99 from the RL group.
Patients received over the first 12 h post-CABG 10 ml kg BW−1 HL solution in the HL group versus 30 ml kg BW−1 of RL solution in the RL group.
Measurements and results
Hemodynamic status, body fluid balance and inotrope utilization were compared in the two groups. Post-operative cardiac index increase was significantly higher in HL than in RL (P = 0.02), while mean arterial pressure and other hemodynamic parameters were comparable together with urinary output, indicating similar tissue perfusion in both the groups despite a much lower fluid infusion in the HL group. Therefore, a significant negative fluid balance was achieved in the HL but not in the RL group (−790 ± 71 vs. +43 ± 115 mL 12 h−1, P < 0.0001 for HL and RL, respectively). None of the enrolled patients exhibited side effects related to the treatment.
Half-molar lactate solution is effective for fluid resuscitation in post-CABG patients. Compared to Ringer’s Lactate, its use results in a significantly higher cardiac index with less volume being infused, resulting in a very negative post-operative body fluid balance.
KeywordsCABG Hypertonic lactate Fluid resuscitation Hemodynamic Efficacy Safety
This study was sponsored by Innogene Kalbiotech, Pte. Ltd., 24 Raffles Place 27 – 06 Clifford Centre, Singapore 048621. The half-molar sodium-lactate containing solution is patented (WO 2004/096204 -11/11/04, Gazette 2004/46) and registered (Totilac™). We are grateful to Mr. Gareth Butt for his English corrections to this paper.
Disclosure of interest
Professor Xavier Leverve is member of the Innogene International Scientific Board Advisors.
- 22.Leverve X, Mustafa I, Péronnet F (1998) Pivotal role of lactate in aerobic metabolism. In: Yearbook of intensive care and emergency medicine. J. V. Springer, Berlin, pp 588–596Google Scholar
- 25.King P, Kong MF, Parkin H, MacDonald IA, Barber C, Tattersall RB (1998) Intravenous lactate prevents cerebral dysfunction during hypoglycaemia in insulin-dependent diabetes mellitus. Clin Sci (Lond) 94:157–163Google Scholar
- 36.Levy B, Mansart A, Montemont C, Gibot S, Mallie JP, Regnault V, Lecompte T, Lacolley P (2007) Myocardial lactate deprivation is associated with decreased cardiovascular performance, decreased myocardial energetics, and early death in endotoxic shock. Intensive Care Med 33:495–502PubMedCrossRefGoogle Scholar